Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese investigators disclose TYK2 inhibitors

June 13, 2022

CyanVac's CVXGA-1 provides broad protection against SARS-CoV-2 strains in hamster model

June 13, 2022

Gepotidacin shows efficacy in nonhuman primate model of pneumonic plague

June 13, 2022

University of Southampton patents new HIF inhibitors

June 13, 2022

Advisory board reviews preclinical data for fourth-generation EGFR TKI JIN-A02

June 10, 2022

Senti Biosciences outlines plans for gene circuit technologies and therapeutic pipeline

June 10, 2022

Circuit, synuclein insights reported in Parkinson's disease

June 10, 2022

Novel humanized mouse model of rheumatoid arthritis

June 10, 2022

Circulating miRNAs associated with difficult-to-treat RA

June 10, 2022

Washington University extends research of Hoth's HT-ALZ in mouse model of Alzheimer's disease

June 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...